Clinical Trials for LimmaTech Biologics

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: LimmaTech Biologics

Clinical Trials (4)

NCT06523231
Study to Expand Safety and Immunogenicity Data With Shigella Bioconjugate Vaccine (Shigella4V2) in 9-month-old Infants.
PHASE2Active, not recruiting
110 participants
Started: Apr 7, 2025 · Completed: Feb 28, 2026
1 condition2 sponsors1 location
NCT06719219
A First in Human Trial to Assess the Safety and Immunogenicity of LTB-SA7 Vaccine Against Staphylococcus Aureus.
PHASE1Active, not recruiting
129 participants
Started: Jan 7, 2025 · Completed: May 31, 2026
1 condition4 sponsors1 location
NCT06615375
A Human Challenge Study to Assess Protection of a Shigella Tetravalent Bioconjugate Vaccine
PHASE2Recruiting
120 participants
Started: Nov 12, 2024 · Completed: Jul 31, 2026
1 condition4 sponsors3 locations
NCT06190509
Assessing the Safety, Immune Response, and Early Efficacy of a Candida Vaccine in Women With Recurrent Vulvovaginal Candidiasis: A Randomized Controlled Study
PHASE1/PHASE2Recruiting
251 participants
Started: Dec 6, 2023 · Completed: Dec 31, 2026
1 condition2 sponsors6 locations